3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Postoperative Complications
1
Papillomavirus Infections
1
Colorectal Neoplasms
1
Advanced Hormone Receptor-Positive Breast Carcinoma
1
Interventions
Bevacizumab
37
Oxaliplatin
17
Capecitabine
17
Irinotecan
15
Leucovorin
13
HMPL-013
12
Fluorouracil
12
Cetuximab
11
trifluridine tipiracil drug combination
7
irinotecan sucrosofate
6
tipiracil
5
Trifluridine
5
Specimen Handling
5
Drug Therapy
5
tislelizumab
4
Standard of Care
4
Mitomycin
4
Magnetic Resonance Spectroscopy
4
Injections
4
Folfox protocol
4
trametinib
3
toripalimab
3
pembrolizumab
3
Nivolumab
3
IFL protocol
3
Colonoscopy
3
Blood Specimen Collection
3
Biopsy
3
sotorasib
2
sintilimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Colorectal Neoplasms
×
Clinical Protocols
×
Clear all
NCT07496528
2026-04-06
ACURE
Chang Gung Memorial Hospital
Phase NA
Not yet recruiting
240 enrolled